XML 37 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
NATURE OF THE ORGANIZATION AND BUSINESS (Details Narrative) - USD ($)
 1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
Jan. 18, 2022
Oct. 04, 2021
Oct. 04, 2021
Aug. 04, 2021
Jul. 13, 2021
Jun. 08, 2021
Jun. 08, 2021
Jun. 01, 2021
Jun. 01, 2021
Feb. 11, 2021
Feb. 28, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Jun. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Aug. 22, 2022
Jan. 22, 2021
Apr. 25, 2019
Sep. 30, 2018
Apr. 01, 2016
Common stock, par or stated value per share                       $ 0.01 $ 0.01 $ 0.01   $ 0.01 $ 0.01 $ 0.01 $ 0.01        
Payments to acquire businesses, net of cash acquired $ 460,000                             $ 1,012,395            
Milestone payments 3,460,000                                            
Conversion of Stock, Amount Converted 507,000                                            
Consideration paid                               9,100,000              
Business acquisition periodic payments                     $ 500,000                        
Percentage of payment acquistion                     15.00%                        
[custom:AssetAcquisitionClosing]                     $ 62,500                        
Partnership description         On July 13, 2021, the Company, on behalf of its customers, entered into an agreement to engage Quest Diagnostics Incorporated (“Quest Diagnostics”) as the Company’s laboratory services provider to perform certain clinical laboratory diagnostic services based on orders submitted to Quest Diagnostics by licensed health care providers who are under contract with the Company and are authorized under U.S. federal or state law to order laboratory tests. Patients of LifeMD Inc.’s affiliated providers gain access to more than 150 of the most ordered laboratory tests at preferential prices, and which can be completed in the comfort, safety, and convenience of their home or office, or at any one of Quest Diagnostics’ 2,000 facilities.                                    
Concentration Risk, Patent and Other Rights, description       Particle Health enables healthcare companies by offering simple, secure access to vital medical data. With Particle Health’s platform and patient consent, licensed affiliated medical providers on the LifeMD primary care platform gain instant access to comprehensive patient health records, therefore enabling best-in-class, personalized care through a deeper understanding of their patients’ medical histories.                                      
Sale of common stock under ATM, shares                         400,000                    
Issuance of private placement   $ 32,000,000 $ 15,000,000.0     $ 60,000,000 $ 60,000,000   $ 15,000,000.0             13,495,270            
Notes payable, current                               $ 63,400          
Purchase agreement payable               $ 15,000,000.0 15,000,000.0                            
Going concern ability description           Under the 2021 Shelf at the time of effectiveness, the Company had the ability to raise up to $150 million by selling common stock, preferred stock, debt securities, warrants, and units. In conjunction with the 2021 Shelf, the Company also entered into the ATM Sales Agreement whereby the Company may offer and sell, from time to time, shares of common stock having an aggregate offering price of up to $60 million                       Under the 2021 Shelf at the time of effectiveness, the Company had the ability to raise up to $150 million by selling common stock, preferred stock, debt securities, warrants, and units.          
Proceeds from issuance of common stock                               $ 493,481            
New issues                           $ 493,481 $ 58,500,000                
Proceeds from stock issuance   55,300,000                                          
Preferred stock, par or stated value per share                       $ 0.0001 $ 0.0001 $ 0.0001   $ 0.0001 $ 0.0001            
Common stock, shares, issued                         31,457,775     31,457,775   30,704,434          
Preferred stock, dividend                               $ 2.21875              
Percentage of preferred stock liquidation preference                               8.875%              
Preferred stock, liquidation preference                         $ 25.00     $ 25.00              
Accumulated deficit                         $ 177,851,083     $ 177,851,083   $ 141,921,085          
Cash                         $ 3,400,000     $ 3,400,000              
Series A Preferred Stock [Member]                                              
Preferred stock, shares issued                         1,400,000     1,400,000   1,400,000          
Preferred stock, par or stated value per share                         $ 0.0001     $ 0.0001   $ 0.0001          
Underwriting shares                       210,000   210,000     210,000            
Shares And Securities [Member]                                              
Raise up funds           $ 150,000,000 $ 150,000,000                                
Common Stock [Member]                                              
Sale of common stock under ATM, shares                           70,786     70,786            
Proceeds from issuance of common stock                           $ 493,481                  
New issues                           $ 708     $ 493,481            
Management [Member]                                              
Accumulated deficit                         $ 178,000,000     $ 178,000,000              
IPO [Member]                                              
Price per share                       6.00   6.00     6.00            
Asset Purchase Agreement [Member]                                              
Consideration paid                     $ 4,000,000.0                        
Securities Purchase Agreement [Member]                                              
Early repayment of subordinated debt               15,000,000.0                              
Securities Purchase Agreement [Member] | Investors [Member]                                              
Notes payable, current               $ 15,000,000.0 $ 15,000,000.0                            
Purchase of warrants               1,500,000 1,500,000                            
Warrant, exercise price               $ 12.00 $ 12.00                            
Warrant or right, reason for issuance, description                 500,000 warrants were issued to the Purchaser upon closing with the remaining 1,000,000 warrants only issued to the Purchaser in increments of 500,000 if the Debenture remains outstanding for twelve and twenty four months, respectively, following the closing date of the June 1, 2021 Purchase Agreement.                            
Debt instrument, term                 3 years                            
Securities Purchase Agreement [Member] | Private Placement [Member] | Investors [Member]                                              
Common stock, par or stated value per share                   $ 0.01                          
Sale of common stock under ATM, shares                   608,696                          
Stock issued price per share                   $ 23                          
Issuance of private placement                   $ 13,500,000                          
Securities Purchase Agreement [Member] | Private Placement [Member] | Investors [Member] | Purchase Price [Member]                                              
Issuance of private placement                   $ 14,000,000.0                          
ATM Sales Agreement [Member]                                              
Proceeds from stock issuance                               59,500,000              
Shelf Agreement [Member]                                              
Proceeds from stock issuance                               $ 32,000,000              
Preferred Underwriting Agreement [Member]                                              
Preferred stock, shares issued                       1,400,000   1,400,000     1,400,000            
Preferred stock, dividend rate, percentage                       8.875%                      
Preferred Underwriting Agreement [Member] | Series A Preferred Stock [Member]                                              
Price per share                       25.00   25.00     25.00            
Common Underwriting Agreement [Member]                                              
Common stock, shares, issued                       3,833,334   3,833,334     3,833,334            
BRiley Securities Inc [Member]                                              
Common stock, shares, issued                       500,000   500,000     500,000            
Sales Agreement [Member]                                              
Issuance of private placement   $ 59,500,000                                          
Second Anniversaries [Member]                                              
Milestone payments $ 1,730,000                                            
LegalSimpli Software, LLC [Member]                                              
Voting interests acquired                                           51.00%  
Work Simpli Software Llc [Member]                                              
Equity interest in acquiree, percentage                                           51.00%  
Immudyne PR LLC [Member]                                              
Equity method investment, ownership percentage                                             78.20%
Conversion Labs PR [Member]                                              
Equity method investment, ownership percentage                                         100.00%    
LegalSimpli Software, LLC [Member]                                              
Equity method investment, ownership percentage                         73.64%     73.64%       85.60%      
WorkSimpli [Member]                                              
Equity method investment, ownership percentage                         73.64%     73.64%           85.60%